Use of cannabinoid-based medicine among older residential care recipients diagnosed with dementia: study protocol for a double-blind randomised crossover trial

Amanda Timler(The University of Notre Dame Australia), Jim Codde(The University of Notre Dame Australia), Max Bulsara(The University of Notre Dame Australia), Alistair Vickery, Caroline Bulsara(The University of Notre Dame Australia), Jill Smith(Manchester Academic Health Science Centre)
Trials
February 14, 2020
10.1186/s13063-020-4085-x
Cited by 23

Related Papers

The quanitification of drug caused morbidity and mortality in Australia: Part 1
|UWA Profiles and Research Repository (University of Western Australia)|1995|470
Poor Long-Term Survival in Patients With Moderate Aortic Stenosis
|Journal of the American College of Cardiology|2019|418
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial
|BMJ|2020|293
SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome
|Nature Genetics|2017|162
REGRESSION OF LIVER METASTASES FOLLOWING TREATMENT WITH YTTRIUM‐90 MICROSPHERES
|Australian and New Zealand Journal of Surgery|1992|145